<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26751468</PMID><DateCompleted><Year>2016</Year><Month>10</Month><Day>07</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1999-4915</ISSN><JournalIssue CitedMedium="Internet"><Volume>8</Volume><Issue>1</Issue><PubDate><Year>2016</Year><Month>Jan</Month><Day>06</Day></PubDate></JournalIssue><Title>Viruses</Title><ISOAbbreviation>Viruses</ISOAbbreviation></Journal><ArticleTitle>MicroRNA and Pathogenesis of Enterovirus Infection.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">11</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/v8010011</ELocationID><Abstract><AbstractText>There are no currently available specific antiviral therapies for non-polio Enterovirus infections. Although several vaccines have entered clinical trials, the efficacy requires further evaluation, particularly for cross-strain protective activity. Curing patients with viral infections is a public health problem due to antigen alterations and drug resistance caused by the high genomic mutation rate. To conquer these limits in the development of anti-Enterovirus treatments, a comprehensive understanding of the interactions between Enterovirus and host cells is urgently needed. MicroRNA (miRNA) constitutes the biggest family of gene regulators in mammalian cells and regulates almost a half of all human genes. The roles of miRNAs in Enterovirus pathogenesis have recently begun to be noted. In this review, we shed light on recent advances in the understanding of Enterovirus infection-modulated miRNAs. The impacts of altered host miRNAs on cellular processes, including immune escape, apoptosis, signal transduction, shutdown of host protein synthesis and viral replication, are discussed. Finally, miRNA-based medication provides a promising strategy for the development of antiviral therapy.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ho</LastName><ForeName>Bing-Ching</ForeName><Initials>BC</Initials><AffiliationInfo><Affiliation>Department of Clinical Laboratory Sciences and Medical Biotechnology, College of Medicine, National Taiwan University, No. 1 Chang-Te Street, Taipei 10048, Taiwan. f94424002@ntu.edu.tw.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center of Genomic Medicine, National Taiwan University, Taipei 10048, Taiwan. f94424002@ntu.edu.tw.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Pan-Chyr</ForeName><Initials>PC</Initials><AffiliationInfo><Affiliation>Center of Genomic Medicine, National Taiwan University, Taipei 10048, Taiwan. pcyang@ntu.edu.tw.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, National Taiwan University Hospital, Taipei 10048, Taiwan. pcyang@ntu.edu.tw.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Biomedical Sciences, Academia Sinica, Taipei 10048, Taiwan. pcyang@ntu.edu.tw.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Sung-Liang</ForeName><Initials>SL</Initials><AffiliationInfo><Affiliation>Department of Clinical Laboratory Sciences and Medical Biotechnology, College of Medicine, National Taiwan University, No. 1 Chang-Te Street, Taipei 10048, Taiwan. slyu@ntu.edu.tw.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center of Genomic Medicine, National Taiwan University, Taipei 10048, Taiwan. slyu@ntu.edu.tw.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Optoelectronic Biomedicine, College of Medicine, National Taiwan University, Taipei 10048, Taiwan. slyu@ntu.edu.tw.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate Institute of Pathology, College of Medicine, National Taiwan University, Taipei 10048, Taiwan. slyu@ntu.edu.tw.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Laboratory Medicine, National Taiwan University Hospital, Taipei 10048, Taiwan. slyu@ntu.edu.tw.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>01</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Viruses</MedlineTA><NlmUniqueID>101509722</NlmUniqueID><ISSNLinking>1999-4915</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D035683">MicroRNAs</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="N">Enterovirus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="N">Enterovirus Infections</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D035683" MajorTopicYN="N">MicroRNAs</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014774" MajorTopicYN="N">Virulence</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">apoptosis</Keyword><Keyword MajorTopicYN="N">microRNA</Keyword><Keyword MajorTopicYN="N">non-coding RNA</Keyword><Keyword MajorTopicYN="N">protein synthesis shutdown</Keyword><Keyword MajorTopicYN="N">virus replication</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>10</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2015</Year><Month>12</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>12</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>1</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>1</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>10</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2016</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26751468</ArticleId><ArticleId IdType="pmc">PMC4728571</ArticleId><ArticleId IdType="doi">10.3390/v8010011</ArticleId><ArticleId IdType="pii">v8010011</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Badran S.A., Midgley S., Andersen P., Bottiger B. Clinical and virological features of enterovirus 71 infections in Denmark, 2005 to 2008. Scand. J. Infect. Dis. 2011;43:642&#8211;648. doi: 10.3109/00365548.2011.577094.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/00365548.2011.577094</ArticleId><ArticleId IdType="pubmed">21526904</ArticleId></ArticleIdList></Reference><Reference><Citation>Bian L., Wang Y., Yao X., Mao Q., Xu M., Liang Z. Coxsackievirus A6: A new emerging pathogen causing hand, foot and mouth disease outbreaks worldwide. Expert Rev. Anti-Infect. Ther. 2015;13:1061&#8211;1071. doi: 10.1586/14787210.2015.1058156.</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/14787210.2015.1058156</ArticleId><ArticleId IdType="pubmed">26112307</ArticleId></ArticleIdList></Reference><Reference><Citation>Chua K.B., Kasri A.R. Hand foot and mouth disease due to enterovirus 71 in Malaysia. Virol. Sin. 2011;26:221&#8211;228. doi: 10.1007/s12250-011-3195-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12250-011-3195-8</ArticleId><ArticleId IdType="pmc">PMC8222466</ArticleId><ArticleId IdType="pubmed">21847753</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaunt E., Harvala H., Osterback R., Sreenu V.B., Thomson E., Waris M., Simmonds P. Genetic characterization of human coxsackievirus A6 variants associated with atypical hand, foot and mouth disease: A potential role of recombination in emergence and pathogenicity. J. Gen. Virol. 2015;96:1067&#8211;1079. doi: 10.1099/vir.0.000062.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.000062</ArticleId><ArticleId IdType="pmc">PMC4631059</ArticleId><ArticleId IdType="pubmed">25614593</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan H., Wang J., Wang C., Yang M., Liu L., Yang G., Ma X. Etiology of multiple Non-EV71 and non-CVA16 enteroviruses associated with hand, foot and mouth disease in Jinan, China, 2009&#8212;June 2013. PLoS ONE. 2015;10:11. doi: 10.1371/journal.pone.0142733.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0142733</ArticleId><ArticleId IdType="pmc">PMC4642993</ArticleId><ArticleId IdType="pubmed">26562154</ArticleId></ArticleIdList></Reference><Reference><Citation>Honkanen H., Oikarinen S., Pakkanen O., Ruokoranta T., Pulkki M.M., Laitinen O.H., Tauriainen S., Korpela S., Lappalainen M., Vuorinen T., et al. Human enterovirus 71 strains in the background population and in hospital patients in Finland. J. Clin. Virol. 2013;56:348&#8211;353. doi: 10.1016/j.jcv.2012.11.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2012.11.018</ArticleId><ArticleId IdType="pubmed">23261080</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang X., Wei H., Wu S., Du Y., Liu L., Su J., Xu Y., Wang H., Li X., Wang Y., et al. Epidemiological and etiological characteristics of hand, foot, and mouth disease in Henan, China, 2008&#8211;2013. Sci. Rep. 2015;5 doi: 10.1038/srep08904.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep08904</ArticleId><ArticleId IdType="pmc">PMC4354091</ArticleId><ArticleId IdType="pubmed">25754970</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim H., Kang B., Hwang S., Lee S.W., Cheon D.S., Kim K., Jeong Y.S., Hyeon J.Y. Clinical and enterovirus findings associated with acute flaccid paralysis in the Republic of Korea during the recent decade. J. Med. Virol. 2014;86:1584&#8211;1589. doi: 10.1002/jmv.23763.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.23763</ArticleId><ArticleId IdType="pubmed">24114945</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee T.C., Guo H.R., Su H.J., Yang Y.C., Chang H.L., Chen K.T. Diseases caused by enterovirus 71 infection. Pediatr. Infect. Dis. J. 2009;28:904&#8211;910. doi: 10.1097/INF.0b013e3181a41d63.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0b013e3181a41d63</ArticleId><ArticleId IdType="pubmed">20118685</ArticleId></ArticleIdList></Reference><Reference><Citation>Linsuwanon P., Puenpa J., Huang S.W., Wang Y.F., Mauleekoonphairoj J., Wang J.R., Poovorawan Y. Epidemiology and seroepidemiology of human enterovirus 71 among Thai populations. J. Biomed. Sci. 2014;21:1110&#8211;1186. doi: 10.1186/1423-0127-21-16.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1423-0127-21-16</ArticleId><ArticleId IdType="pmc">PMC3937078</ArticleId><ArticleId IdType="pubmed">24548776</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh S., Poh C.L., Chow V.T. Complete sequence analyses of enterovirus 71 strains from fatal and non-fatal cases of the hand, foot and mouth disease outbreak in Singapore (2000) Microbiol. Immunol. 2002;46:801&#8211;808. doi: 10.1111/j.1348-0421.2002.tb02767.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1348-0421.2002.tb02767.x</ArticleId><ArticleId IdType="pubmed">12516778</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu J.S., Zhao N., Pan H., Wang C.M., Wu B., Zhang H.M., He H.X., Liu D., Amer S., Liu S.L. Patterns of polymorphism and divergence in the VP1 gene of enterovirus 71 circulating in the Asia-Pacific region between 1994 and 2013. J. Virol. Methods. 2013;193:713&#8211;728. doi: 10.1016/j.jviromet.2013.07.051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jviromet.2013.07.051</ArticleId><ArticleId IdType="pubmed">23933074</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu W.H., Kuo T.C., Lin Y.T., Huang S.W., Liu H.F., Wang J., Chen Y.M. Molecular epidemiology of enterovirus 71 infection in the central region of Taiwan from 2002 to 2012. PLoS ONE. 2013;8:11. doi: 10.1371/journal.pone.0083711.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0083711</ArticleId><ArticleId IdType="pmc">PMC3877097</ArticleId><ArticleId IdType="pubmed">24391812</ArticleId></ArticleIdList></Reference><Reference><Citation>Fields B.N., Knipe D.M., Howley P.M. Fields' Virology. Wolters Kluwer Health/Lippincott Williams &amp; Wilkins; Philadelphia, PA, USA: 2007.</Citation></Reference><Reference><Citation>Bible J.M., Pantelidis P., Chan P.K., Tong C.Y. Genetic evolution of enterovirus 71: Epidemiological and pathological implications. Rev. Med. Virol. 2007;17:371&#8211;379. doi: 10.1002/rmv.538.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.538</ArticleId><ArticleId IdType="pubmed">17487831</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon T., Lewthwaite P., Perera D., Cardosa M.J., McMinn P., Ooi M.H. Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect. Dis. 2010;10:778&#8211;790. doi: 10.1016/S1473-3099(10)70194-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(10)70194-8</ArticleId><ArticleId IdType="pubmed">20961813</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimizu H., Utama A., Yoshii K., Yoshida H., Yoneyama T., Sinniah M., Yusof M.A., Okuno Y., Okabe N., Shih S.R., et al. Enterovirus 71 from fatal and nonfatal cases of hand, foot and mouth disease epidemics in Malaysia, Japan and Taiwan in 1997&#8211;1998. Jpn J. Infect. Dis. 1999;52:12&#8211;15.</Citation><ArticleIdList><ArticleId IdType="pubmed">10808253</ArticleId></ArticleIdList></Reference><Reference><Citation>McMinn P., Stratov I., Nagarajan L., Davis S. Neurological manifestations of enterovirus 71 infection in children during an outbreak of hand, foot, and mouth disease in Western Australia. Clin. Infect. Dis. 2001;32:236&#8211;242. doi: 10.1086/318454.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/318454</ArticleId><ArticleId IdType="pubmed">11170913</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryu W.S., Kang B., Hong J., Hwang S., Kim A., Kim J., Cheon D.S. Enterovirus 71 infection with central nervous system involvement, South Korea. Emerg. Infect. Dis. 2010;16:1764&#8211;1766. doi: 10.3201/eid1611.100104.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid1611.100104</ArticleId><ArticleId IdType="pmc">PMC3294506</ArticleId><ArticleId IdType="pubmed">21029539</ArticleId></ArticleIdList></Reference><Reference><Citation>Pons-Salort M., Parker E.P., Grassly N.C. The epidemiology of non-polio enteroviruses: Recent advances and outstanding questions. Curr. Opin. Infect. Dis. 2015;28:479&#8211;487. doi: 10.1097/QCO.0000000000000187.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/QCO.0000000000000187</ArticleId><ArticleId IdType="pmc">PMC6624138</ArticleId><ArticleId IdType="pubmed">26203854</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang L.Y., Huang L.M., Gau S.S., Wu Y.Y., Hsia S.H., Fan T.Y., Lin K.L., Huang Y.C., Lu C.Y., Lin T.Y. Neurodevelopment and cognition in children after enterovirus 71 infection. N. Engl. J. Med. 2007;356:1226&#8211;1234. doi: 10.1056/NEJMoa065954.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa065954</ArticleId><ArticleId IdType="pubmed">17377160</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y.F., Chou C.T., Lei H.Y., Liu C.C., Wang S.M., Yan J.J., Su I.J., Wang J.R., Yeh T.M., Chen S.H., et al. A mouse-adapted enterovirus 71 strain causes neurological disease in mice after oral infection. J. Virol. 2004;78:7916&#8211;7924. doi: 10.1128/JVI.78.15.7916-7924.2004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.78.15.7916-7924.2004</ArticleId><ArticleId IdType="pmc">PMC446098</ArticleId><ArticleId IdType="pubmed">15254164</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang L.Y., Huang Y.C., Lin T.Y. Fulminant neurogenic pulmonary oedema with hand, foot, and mouth disease. Lancet. 1998;352:36736&#8211;36738.</Citation><ArticleIdList><ArticleId IdType="pubmed">9717926</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C.C., Liu C.C., Chang Y.C., Chen C.Y., Wang S.T., Yeh T.F. Neurologic complications in children with enterovirus 71 infection. N. Engl. J. Med. 1999;341:936&#8211;942. doi: 10.1056/NEJM199909233411302.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199909233411302</ArticleId><ArticleId IdType="pubmed">10498488</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin Y.W., Wang S.W., Tung Y.Y., Chen S.H. Enterovirus 71 infection of human dendritic cells. Exp. Biol. Med. 2009;234:1166&#8211;1173. doi: 10.3181/0903-RM-116.</Citation><ArticleIdList><ArticleId IdType="doi">10.3181/0903-RM-116</ArticleId><ArticleId IdType="pubmed">19596831</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitton J.L., Cornell C.T., Feuer R. Host and virus determinants of picornavirus pathogenesis and tropism. Nat. Rev. Microbiol. 2005;3:765&#8211;776. doi: 10.1038/nrmicro1284.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrmicro1284</ArticleId><ArticleId IdType="pubmed">16205710</ArticleId></ArticleIdList></Reference><Reference><Citation>Hammond S.M. MicroRNAs as oncogenes. Curr. Opin. Genet. Dev. 2006;16:4&#8211;9. doi: 10.1016/j.gde.2005.12.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gde.2005.12.005</ArticleId><ArticleId IdType="pubmed">16361094</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartel D.P. MicroRNAs: Target recognition and regulatory functions. Cell. 2009;136:215&#8211;233. doi: 10.1016/j.cell.2009.01.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2009.01.002</ArticleId><ArticleId IdType="pmc">PMC3794896</ArticleId><ArticleId IdType="pubmed">19167326</ArticleId></ArticleIdList></Reference><Reference><Citation>Ha M., Kim V.N. Regulation of microRNA biogenesis. Nat. Rev. Mol. Cell Biol. 2014;15:509&#8211;524. doi: 10.1038/nrm3838.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm3838</ArticleId><ArticleId IdType="pubmed">25027649</ArticleId></ArticleIdList></Reference><Reference><Citation>Park J.H., Shin C. MicroRNA-directed cleavage of targets: Mechanism and experimental approaches. BMB Rep. 2014;47:417&#8211;423. doi: 10.5483/BMBRep.2014.47.8.109.</Citation><ArticleIdList><ArticleId IdType="doi">10.5483/BMBRep.2014.47.8.109</ArticleId><ArticleId IdType="pmc">PMC4206712</ArticleId><ArticleId IdType="pubmed">24856832</ArticleId></ArticleIdList></Reference><Reference><Citation>Hammond S.M. An overview of microRNAs. Adv. Drug Deliv. Rev. 2015;87:3&#8211;14. doi: 10.1016/j.addr.2015.05.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.addr.2015.05.001</ArticleId><ArticleId IdType="pmc">PMC4504744</ArticleId><ArticleId IdType="pubmed">25979468</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin S., Gregory R.I. MicroRNA biogenesis pathways in cancer. Nat. Rev. Cancer. 2015;15:321&#8211;333. doi: 10.1038/nrc3932.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrc3932</ArticleId><ArticleId IdType="pmc">PMC4859809</ArticleId><ArticleId IdType="pubmed">25998712</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewis B.P., Burge C.B., Bartel D.P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell. 2005;120:15&#8211;20. doi: 10.1016/j.cell.2004.12.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2004.12.035</ArticleId><ArticleId IdType="pubmed">15652477</ArticleId></ArticleIdList></Reference><Reference><Citation>Cullen B.R. Transcription and processing of human microRNA precursors. Mol. Cell. 2004;16:861&#8211;865. doi: 10.1016/j.molcel.2004.12.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2004.12.002</ArticleId><ArticleId IdType="pubmed">15610730</ArticleId></ArticleIdList></Reference><Reference><Citation>Borchert G.M., Lanier W., Davidson B.L. RNA polymerase III transcribes human microRNAs. Nat. Struct. Mol. Biol. 2006;13:1097&#8211;1101. doi: 10.1038/nsmb1167.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nsmb1167</ArticleId><ArticleId IdType="pubmed">17099701</ArticleId></ArticleIdList></Reference><Reference><Citation>Hutvagner G., McLachlan J., Pasquinelli A.E., Balint E., Tuschl T., Zamore P.D. A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA. Science. 2001;293:834&#8211;838. doi: 10.1126/science.1062961.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1062961</ArticleId><ArticleId IdType="pubmed">11452083</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernstein E., Caudy A.A., Hammond S.M., Hannon G.J. Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature. 2001;409:363&#8211;366. doi: 10.1038/35053110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/35053110</ArticleId><ArticleId IdType="pubmed">11201747</ArticleId></ArticleIdList></Reference><Reference><Citation>Grishok A., Pasquinelli A.E., Conte D., Li N., Parrish S., Ha I., Baillie D.L., Fire A., Ruvkun G., Mello C.C. Genes and mechanisms related to RNA interference regulate expression of the small temporal RNAs that control C. elegans developmental timing. Cell. 2001;106:23&#8211;34. doi: 10.1016/S0092-8674(01)00431-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0092-8674(01)00431-7</ArticleId><ArticleId IdType="pubmed">11461699</ArticleId></ArticleIdList></Reference><Reference><Citation>Hammond S.M., Bernstein E., Beach D., Hannon G.J. An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells. Nature. 2000;404:293&#8211;296.</Citation><ArticleIdList><ArticleId IdType="pubmed">10749213</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu L., Fan J., Belasco J.G. MicroRNAs direct rapid deadenylation of mRNA. Proc. Natl. Acad. Sci. USA. 2006;103:4034&#8211;4039. doi: 10.1073/pnas.0510928103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0510928103</ArticleId><ArticleId IdType="pmc">PMC1449641</ArticleId><ArticleId IdType="pubmed">16495412</ArticleId></ArticleIdList></Reference><Reference><Citation>Standart N., Jackson R.J. MicroRNAs repress translation of m7Gppp-capped target mRNAs in vitro by inhibiting initiation and promoting deadenylation. Genes Dev. 2007;21:1975&#8211;1982. doi: 10.1101/gad.1591507.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.1591507</ArticleId><ArticleId IdType="pubmed">17699746</ArticleId></ArticleIdList></Reference><Reference><Citation>Duursma A.M., Kedde M., Schrier M., le Sage C., Agami R. miR-148 targets human DNMT3b protein coding region. RNA. 2008;14:872&#8211;877. doi: 10.1261/rna.972008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1261/rna.972008</ArticleId><ArticleId IdType="pmc">PMC2327368</ArticleId><ArticleId IdType="pubmed">18367714</ArticleId></ArticleIdList></Reference><Reference><Citation>Rigoutsos I. New tricks for animal microRNAS: Targeting of amino acid coding regions at conserved and nonconserved sites. Cancer Res. 2009;69:3245&#8211;3248. doi: 10.1158/0008-5472.CAN-09-0352.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/0008-5472.CAN-09-0352</ArticleId><ArticleId IdType="pubmed">19351814</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee I., Ajay S.S., Yook J.I., Kim H.S., Hong S.H., Kim N.H., Dhanasekaran S.M., Chinnaiyan A.M., Athey B.D. New class of microRNA targets containing simultaneous 5&#8242;-UTR and 3&#8242;-UTR interaction sites. Genom. Res. 2009;19:1175&#8211;1183. doi: 10.1101/gr.089367.108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gr.089367.108</ArticleId><ArticleId IdType="pmc">PMC2704433</ArticleId><ArticleId IdType="pubmed">19336450</ArticleId></ArticleIdList></Reference><Reference><Citation>Grey F., Tirabassi R., Meyers H., Wu G., McWeeney S., Hook L., Nelson J.A. A viral microRNA down-regulates multiple cell cycle genes through mRNA 5&#8242;AUTRs. PLoS Pathog. 2010;6:11. doi: 10.1371/journal.ppat.1000967.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1000967</ArticleId><ArticleId IdType="pmc">PMC2891821</ArticleId><ArticleId IdType="pubmed">20585629</ArticleId></ArticleIdList></Reference><Reference><Citation>Croce C.M. Causes and consequences of microRNA dysregulation in cancer. Nat. Rev. Genet. 2009;10:704&#8211;714. doi: 10.1038/nrg2634.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrg2634</ArticleId><ArticleId IdType="pmc">PMC3467096</ArticleId><ArticleId IdType="pubmed">19763153</ArticleId></ArticleIdList></Reference><Reference><Citation>Umbach J.L., Cullen B.R. The role of RNAi and microRNAs in animal virus replication and antiviral immunity. Genes Dev. 2009;23:1151&#8211;1164. doi: 10.1101/gad.1793309.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.1793309</ArticleId><ArticleId IdType="pmc">PMC2763533</ArticleId><ArticleId IdType="pubmed">19451215</ArticleId></ArticleIdList></Reference><Reference><Citation>Winter J., Jung S., Keller S., Gregory R.I., Diederichs S. Many roads to maturity: MicroRNA biogenesis pathways and their regulation. Nat. Cell Biol. 2009;11:228&#8211;234. doi: 10.1038/ncb0309-228.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncb0309-228</ArticleId><ArticleId IdType="pubmed">19255566</ArticleId></ArticleIdList></Reference><Reference><Citation>Umbach J.L., Kramer M.F., Jurak I., Karnowski H.W., Coen D.M., Cullen B.R. MicroRNAs expressed by herpes simplex virus 1 during latent infection regulate viral mRNAs. Nature. 2008;454:780&#8211;783. doi: 10.1038/nature07103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature07103</ArticleId><ArticleId IdType="pmc">PMC2666538</ArticleId><ArticleId IdType="pubmed">18596690</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfeffer S., Zavolan M., Grasser F.A., Chien M., Russo J.J., Ju J., John B., Enright A.J., Marks D., Sander C., et al. Identification of virus-encoded microRNAs. Science. 2004;304:734&#8211;736. doi: 10.1126/science.1096781.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1096781</ArticleId><ArticleId IdType="pubmed">15118162</ArticleId></ArticleIdList></Reference><Reference><Citation>Gottwein E., Mukherjee N., Sachse C., Frenzel C., Majoros W.H., Chi J.T., Braich R., Manoharan M., Soutschek J., Ohler U., et al. A viral microRNA functions as an orthologue of cellular miR-155. Nature. 2007;450:1096&#8211;1099. doi: 10.1038/nature05992.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature05992</ArticleId><ArticleId IdType="pmc">PMC2614920</ArticleId><ArticleId IdType="pubmed">18075594</ArticleId></ArticleIdList></Reference><Reference><Citation>Triboulet R., Mari B., Lin Y.L., Chable-Bessia C., Bennasser Y., Lebrigand K., Cardinaud B., Maurin T., Barbry P., Baillat V., et al. Suppression of microRNA-silencing pathway by HIV-1 during virus replication. Science. 2007;315:1579&#8211;1582. doi: 10.1126/science.1136319.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1136319</ArticleId><ArticleId IdType="pubmed">17322031</ArticleId></ArticleIdList></Reference><Reference><Citation>Jopling C.L., Yi M., Lancaster A.M., Lemon S.M., Sarnow P. Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA. Science. 2005;309:1577&#8211;1581. doi: 10.1126/science.1113329.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1113329</ArticleId><ArticleId IdType="pubmed">16141076</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye X., Zhang H.M., Qiu Y., Hanson P.J., Hemida M.G., Wei W., Hoodless P.A., Chu F., Yang D. Coxsackievirus-induced miR-21 disrupts cardiomyocyte interactions via the downregulation of intercalated disk components. PLoS Pathog. 2014;10:11. doi: 10.1371/journal.ppat.1004070.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1004070</ArticleId><ArticleId IdType="pmc">PMC3983067</ArticleId><ArticleId IdType="pubmed">24722419</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang Y.L., Ho B.C., Sher S., Yu S.L., Yang P.C. miR-146a and miR-370 coordinate enterovirus 71-induced cell apoptosis through targeting SOS1 and GADD45&#946;. Cell Microbiol. 2015;17:802&#8211;818. doi: 10.1111/cmi.12401.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cmi.12401</ArticleId><ArticleId IdType="pubmed">25469565</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng Z., Ke X., Wang M., He S., Li Q., Zheng C., Zhang Z., Liu Y., Wang H. Human microRNA hsa-miR-296-5p suppresses enterovirus 71 replication by targeting the viral genome. J. Virol. 2013;87:5645&#8211;5656. doi: 10.1128/JVI.02655-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02655-12</ArticleId><ArticleId IdType="pmc">PMC3648165</ArticleId><ArticleId IdType="pubmed">23468506</ArticleId></ArticleIdList></Reference><Reference><Citation>Tong L., Lin L., Wu S., Guo Z., Wang T., Qin Y., Wang R., Zhong X., Wu X., Wang Y., et al. MiR-10a* up-regulates coxsackievirus B3 biosynthesis by targeting the 3D-coding sequence. Nucleic Acids Res. 2013;41:3760&#8211;3771. doi: 10.1093/nar/gkt058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkt058</ArticleId><ArticleId IdType="pmc">PMC3616696</ArticleId><ArticleId IdType="pubmed">23389951</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho B.C., Yu I.S., Lu L.F., Rudensky A., Chen H.Y., Tsai C.W., Chang Y.L., Wu C.T., Chang L.Y., Shih S.R., et al. Inhibition of miR-146a prevents enterovirus-induced death by restoring the production of type I interferon. Nat. Commun. 2014;5 doi: 10.1038/ncomms4344.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms4344</ArticleId><ArticleId IdType="pubmed">24561744</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho B.C., Yu S.L., Chen J.J., Chang S.Y., Yan B.S., Hong Q.S., Singh S., Kao C.L., Chen H.Y., Su K.Y., et al. Enterovirus-induced miR-141 contributes to shutoff of host protein translation by targeting the translation initiation factor eIF4E. Cell Host Microbe. 2011;9:58&#8211;69. doi: 10.1016/j.chom.2010.12.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2010.12.001</ArticleId><ArticleId IdType="pubmed">21238947</ArticleId></ArticleIdList></Reference><Reference><Citation>Klotman M.E., Chang T.L. Defensins in innate antiviral immunity. Nat. Rev. Immunol. 2006;6:447&#8211;456. doi: 10.1038/nri1860.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri1860</ArticleId><ArticleId IdType="pubmed">16724099</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson S.S., Wiens M.E., Smith J.G. Antiviral mechanisms of human defensins. J. Mol. Biol. 2013;425:4965&#8211;4980. doi: 10.1016/j.jmb.2013.09.038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2013.09.038</ArticleId><ArticleId IdType="pmc">PMC3842434</ArticleId><ArticleId IdType="pubmed">24095897</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawai T., Akira S. Innate immune recognition of viral infection. Nat. Immunol. 2006;7:131&#8211;137. doi: 10.1038/ni1303.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni1303</ArticleId><ArticleId IdType="pubmed">16424890</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson M.R., Kaminski J.J., Kurt-Jones E.A., Fitzgerald K.A. Pattern recognition receptors and the innate immune response to viral infection. Viruses. 2011;3:920&#8211;940. doi: 10.3390/v3060920.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v3060920</ArticleId><ArticleId IdType="pmc">PMC3186011</ArticleId><ArticleId IdType="pubmed">21994762</ArticleId></ArticleIdList></Reference><Reference><Citation>Biron C.A., Nguyen K.B., Pien G.C., Cousens L.P., Salazar-Mather T.P. Natural killer cells in antiviral defense: Function and regulation by innate cytokines. Annu. Rev. Immunol. 1999;17:189&#8211;220. doi: 10.1146/annurev.immunol.17.1.189.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.immunol.17.1.189</ArticleId><ArticleId IdType="pubmed">10358757</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Bon A., Schiavoni G., D&#8217;Agostino G., Gresser I., Belardelli F., Tough D.F. Type I interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo. Immunity. 2001;14:461&#8211;470. doi: 10.1016/S1074-7613(01)00126-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1074-7613(01)00126-1</ArticleId><ArticleId IdType="pubmed">11336691</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen K.B., Watford W.T., Salomon R., Hofmann S.R., Pien G.C., Morinobu A., Gadina M., O&#8217;Shea J.J., Biron C.A. Critical role for STAT4 activation by type 1 interferons in the interferon-&#947; response to viral infection. Science. 2002;297:2063&#8211;2066. doi: 10.1126/science.1074900.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1074900</ArticleId><ArticleId IdType="pubmed">12242445</ArticleId></ArticleIdList></Reference><Reference><Citation>Tough D.F., Sun S., Zhang X., Sprent J. Stimulation of naive and memory T cells by cytokines. Immunol. Rev. 1999;170:39&#8211;47. doi: 10.1111/j.1600-065X.1999.tb01327.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-065X.1999.tb01327.x</ArticleId><ArticleId IdType="pubmed">10566140</ArticleId></ArticleIdList></Reference><Reference><Citation>Ichimura H., Shimase K., Tamura I., Kaneto E., Kurimura O., Aramitsu Y., Kurimura T. Neutralizing antibody and interferon-&#945; in cerebrospinal fluids and sera of acute aseptic meningitis. J. Med. Virol. 1985;15:231&#8211;237. doi: 10.1002/jmv.1890150304.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.1890150304</ArticleId><ArticleId IdType="pubmed">3981146</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu M.L., Lee Y.P., Wang Y.F., Lei H.Y., Liu C.C., Wang S.M., Su I.J., Wang J.R., Yeh T.M., Chen S.H., et al. Type I interferons protect mice against enterovirus 71 infection. J. Gen. Virol. 2005;86Pt 12:3263&#8211;3269. doi: 10.1099/vir.0.81195-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.81195-0</ArticleId><ArticleId IdType="pubmed">16298971</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu C., He X., Zheng Z., Zhang Z., Wei C., Guan K., Hou L., Zhang B., Zhu L., Cao Y., et al. Downregulation of microRNA miR-526a by enterovirus inhibits RIG-I-dependent innate immune response. J. Virol. 2014;88:11356&#8211;11368. doi: 10.1128/JVI.01400-14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01400-14</ArticleId><ArticleId IdType="pmc">PMC4178780</ArticleId><ArticleId IdType="pubmed">25056901</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Q., Xiao Z., He F., Zou J., Wu S., Liu Z. MicroRNAs regulate the pathogenesis of CVB3-induced viral myocarditis. Intervirology. 2013;56:104&#8211;113. doi: 10.1159/000343750.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000343750</ArticleId><ArticleId IdType="pubmed">23183417</ArticleId></ArticleIdList></Reference><Reference><Citation>Bao J.L., Lin L. MiR-155 and miR-148a reduce cardiac injury by inhibiting NF-&#954;B pathway during acute viral myocarditis. Eur. Rev. Med. Pharmacol. Sci. 2014;18:2349&#8211;2356.</Citation><ArticleIdList><ArticleId IdType="pubmed">25219837</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y., Xie J., Xu X., Wang J., Ao F., Wan Y., Zhu Y. MicroRNA-548 down-regulates host antiviral response via direct targeting of IFN-lambda1. Protein Cell. 2013;4:130&#8211;141. doi: 10.1007/s13238-012-2081-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13238-012-2081-y</ArticleId><ArticleId IdType="pmc">PMC4875363</ArticleId><ArticleId IdType="pubmed">23150165</ArticleId></ArticleIdList></Reference><Reference><Citation>Shauer A., Gotsman I., Keren A., Zwas D.R., Hellman Y., Durst R., Admon D. Acute viral myocarditis: Current concepts in diagnosis and treatment. Isr. Med. Assoc. J. IMAJ. 2013;15:180&#8211;185.</Citation><ArticleIdList><ArticleId IdType="pubmed">23662385</ArticleId></ArticleIdList></Reference><Reference><Citation>Khong W.X., Foo D.G., Trasti S.L., Tan E.L., Alonso S. Sustained high levels of interleukin-6 contribute to the pathogenesis of enterovirus 71 in a neonate mouse model. J. Virol. 2011;85:3067&#8211;3076. doi: 10.1128/JVI.01779-10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01779-10</ArticleId><ArticleId IdType="pmc">PMC3067852</ArticleId><ArticleId IdType="pubmed">21228224</ArticleId></ArticleIdList></Reference><Reference><Citation>Ch&#8217;ng W.C., Stanbridge E.J., Ong K.C., Wong K.T., Yusoff K., Shafee N. Partial protection against enterovirus 71 (EV71) infection in a mouse model immunized with recombinant Newcastle disease virus capsids displaying the EV71 VP1 fragment. J. Med. Virol. 2011;83:1783&#8211;1791. doi: 10.1002/jmv.22198.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.22198</ArticleId><ArticleId IdType="pubmed">21837796</ArticleId></ArticleIdList></Reference><Reference><Citation>Aubert M., Jerome K.R. Apoptosis prevention as a mechanism of immune evasion. Int. Rev. Immunol. 2003;22:361&#8211;371. doi: 10.1080/08830180305213.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/08830180305213</ArticleId><ArticleId IdType="pubmed">12959750</ArticleId></ArticleIdList></Reference><Reference><Citation>He J., Yue Y., Dong C., Xiong S. MiR-21 confers resistance against CVB3-induced myocarditis by inhibiting PDCD4-mediated apoptosis. Clin. Investig. Med. Med. Clin. Exp. 2013;36:E103&#8211;E111.</Citation><ArticleIdList><ArticleId IdType="pubmed">23544605</ArticleId></ArticleIdList></Reference><Reference><Citation>Du X., Wang H., Xu F., Huang Y., Liu Z., Liu T. Enterovirus 71 induces apoptosis of SHSY5Y human neuroblastoma cells through stimulation of endogenous microRNA let-7b expression. Mol. Med. Rep. 2015;12:953&#8211;959.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4438926</ArticleId><ArticleId IdType="pubmed">25779425</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng Y., Liu X., Zhang S., Lin Y., Yang J., Zhang C. MicroRNA-21 protects against the H2O2-induced injury on cardiac myocytes via its target gene PDCD4. J. Mol. Cell Cardiol. 2009;47:5&#8211;14. doi: 10.1016/j.yjmcc.2009.01.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yjmcc.2009.01.008</ArticleId><ArticleId IdType="pmc">PMC3593965</ArticleId><ArticleId IdType="pubmed">19336275</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu P., Sun H., Zhang L., Hou H., Zhang L., Zhao F., Ge C., Yao M., Wang T., Li J. Isocorydine targets the drug-resistant cellular side population through PDCD4-related apoptosis in hepatocellular carcinoma. Mol. Med. 2012;18:1136&#8211;1146. doi: 10.2119/molmed.2012.00055.</Citation><ArticleIdList><ArticleId IdType="doi">10.2119/molmed.2012.00055</ArticleId><ArticleId IdType="pmc">PMC3474433</ArticleId><ArticleId IdType="pubmed">22714713</ArticleId></ArticleIdList></Reference><Reference><Citation>Frankel L.B., Christoffersen N.R., Jacobsen A., Lindow M., Krogh A., Lund A.H. Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells. J. Biol. Chem. 2008;283:1026&#8211;1033. doi: 10.1074/jbc.M707224200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M707224200</ArticleId><ArticleId IdType="pubmed">17991735</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiang Z., Li L., Lei X., Zhou H., Zhou Z., He B., Wang J. Enterovirus 68 3C protease cleaves TRIF to attenuate antiviral responses mediated by Toll-like receptor 3. J. Virol. 2014;88:6650&#8211;6659. doi: 10.1128/JVI.03138-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.03138-13</ArticleId><ArticleId IdType="pmc">PMC4054379</ArticleId><ArticleId IdType="pubmed">24672048</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei X., Han N., Xiao X., Jin Q., He B., Wang J. Enterovirus 71 3C inhibits cytokine expression through cleavage of the TAK1/TAB1/TAB2/TAB3 complex. J. Virol. 2014;88:9830&#8211;9841. doi: 10.1128/JVI.01425-14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01425-14</ArticleId><ArticleId IdType="pmc">PMC4136319</ArticleId><ArticleId IdType="pubmed">24942571</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuyumcu-Martinez N.M., van Eden M.E., Younan P., Lloyd R.E. Cleavage of poly(A)-binding protein by poliovirus 3C protease inhibits host cell translation: A novel mechanism for host translation shutoff. Mol. Cell Biol. 2004;24:1779&#8211;1790. doi: 10.1128/MCB.24.4.1779-1790.2004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.24.4.1779-1790.2004</ArticleId><ArticleId IdType="pmc">PMC344173</ArticleId><ArticleId IdType="pubmed">14749392</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo R.L., Kung S.H., Hsu Y.Y., Liu W.T. Infection with enterovirus 71 or expression of its 2A protease induces apoptotic cell death. J. Gen. Virol. 2002;83:1367&#8211;1376. doi: 10.1099/0022-1317-83-6-1367.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/0022-1317-83-6-1367</ArticleId><ArticleId IdType="pubmed">12029152</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham K.L., Gustin K.E., Rivera C., Kuyumcu-Martinez N.M., Choe S.S., Lloyd R.E., Sarnow P., Utz P.J. Proteolytic cleavage of the catalytic subunit of DNA-dependent protein kinase during poliovirus infection. J. Virol. 2004;78:6313&#8211;6321. doi: 10.1128/JVI.78.12.6313-6321.2004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.78.12.6313-6321.2004</ArticleId><ArticleId IdType="pmc">PMC416498</ArticleId><ArticleId IdType="pubmed">15163725</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng Q., Langereis M.A., Lork M., Nguyen M., Hato S.V., Lanke K., Emdad L., Bhoopathi P., Fisher P.B., Lloyd R.E., et al. Enterovirus 2Apro targets MDA5 and MAVS in infected cells. J. Virol. 2014;88:3369&#8211;3378. doi: 10.1128/JVI.02712-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02712-13</ArticleId><ArticleId IdType="pmc">PMC3957915</ArticleId><ArticleId IdType="pubmed">24390337</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnabei M.S., Sjaastad F.V., Townsend D., Bedada F.B., Metzger J.M. Severe dystrophic cardiomyopathy caused by the enteroviral protease 2A-mediated C-terminal dystrophin cleavage fragment. Sci. Transl. Med. 2015;7 doi: 10.1126/scitranslmed.aaa4804.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aaa4804</ArticleId><ArticleId IdType="pubmed">26136477</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldstaub D., Gradi A., Bercovitch Z., Grosmann Z., Nophar Y., Luria S., Sonenberg N., Kahana C. Poliovirus 2A protease induces apoptotic cell death. Mol. Cell Biol. 2000;20:1271&#8211;1277. doi: 10.1128/MCB.20.4.1271-1277.2000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.20.4.1271-1277.2000</ArticleId><ArticleId IdType="pmc">PMC85262</ArticleId><ArticleId IdType="pubmed">10648613</ArticleId></ArticleIdList></Reference><Reference><Citation>Corsten M.F., Papageorgiou A., Verhesen W., Carai P., Lindow M., Obad S., Summer G., Coort S.L., Hazebroek M., van Leeuwen R., et al. MicroRNA profiling identifies microRNA-155 as an adverse mediator of cardiac injury and dysfunction during acute viral myocarditis. Circ. Res. 2012;111:415&#8211;425. doi: 10.1161/CIRCRESAHA.112.267443.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.112.267443</ArticleId><ArticleId IdType="pubmed">22715471</ArticleId></ArticleIdList></Reference><Reference><Citation>Lam W.Y., Cheung A.C., Tung C.K., Yeung A.C., Ngai K.L., Lui V.W., Chan P.K., Tsui S.K. miR-466 is putative negative regulator of Coxsackie virus and Adenovirus Receptor. FEBS Lett. 2015;589:246&#8211;254. doi: 10.1016/j.febslet.2014.12.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.febslet.2014.12.006</ArticleId><ArticleId IdType="pubmed">25497012</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu H.F., Ding Y.J., Shen Y.W., Xue A.M., Xu H.M., Luo C.L., Li B.X., Liu Y.L., Zhao Z.Q. MicroRNA-1 represses Cx43 expression in viral myocarditis. Mol. Cell Biochem. 2012;362:141&#8211;148. doi: 10.1007/s11010-011-1136-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11010-011-1136-3</ArticleId><ArticleId IdType="pubmed">22045061</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu H.F., Ding Y.J., Zhang Z.X., Wang Z.F., Luo C.L., Li B.X., Shen Y.W., Tao L.Y., Zhao Z.Q. MicroRNA21 regulation of the progression of viral myocarditis to dilated cardiomyopathy. Mol. Med. Rep. 2014;10:161&#8211;168.</Citation><ArticleIdList><ArticleId IdType="pubmed">24804616</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu L.J., Jiang T., Zhao W., Han J.F., Liu J., Deng Y.Q., Zhu S.Y., Li Y.X., Nian Q.G., Zhang Y., et al. Parallel mRNA and microRNA profiling of HEV71-infected human neuroblastoma cells reveal the up-regulation of miR-1246 in association with DLG3 repression. PLoS ONE. 2014;9:11. doi: 10.1371/journal.pone.0095272.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0095272</ArticleId><ArticleId IdType="pmc">PMC3989279</ArticleId><ArticleId IdType="pubmed">24739954</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye X., Hemida M.G., Qiu Y., Hanson P.J., Zhang H.M., Yang D. MiR-126 promotes coxsackievirus replication by mediating cross-talk of ERK1/2 and Wnt/&#946;-catenin signal pathways. Cell Mol. Life Sci. CMLS. 2013;70:4631&#8211;444. doi: 10.1007/s00018-013-1411-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-013-1411-4</ArticleId><ArticleId IdType="pmc">PMC11113642</ArticleId><ArticleId IdType="pubmed">23811937</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L., Chen X., Shi Y., Zhou B., Du C., Liu Y., Han S., Yin J., Peng B., He X., et al. miR-27a suppresses EV71 replication by directly targeting EGFR. Virus Genes. 2014;49:373&#8211;382. doi: 10.1007/s11262-014-1114-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11262-014-1114-4</ArticleId><ArticleId IdType="pubmed">25212431</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen B.P., Dai H.J., Yang Y.H., Zhuang Y., Sheng R. MicroRNA-23b inhibits enterovirus 71 replication through downregulation of EV71 VPl protein. Intervirology. 2013;56:195&#8211;200. doi: 10.1159/000348504.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000348504</ArticleId><ArticleId IdType="pubmed">23594713</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L., Qin Y., Tong L., Wu S., Wang Q., Jiao Q., Guo Z., Lin L., Wang R., Zhao W., et al. MiR-342-5p suppresses coxsackievirus B3 biosynthesis by targeting the 2C-coding region. Antivir. Res. 2012;93:270&#8211;279. doi: 10.1016/j.antiviral.2011.12.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2011.12.004</ArticleId><ArticleId IdType="pubmed">22197249</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Z., Tien P. MiR373 and miR542-5p regulate the replication of enterovirus 71 in rhabdomyosarcoma cells. Chin. J. Biotechnol. 2014;30:943&#8211;953. (in Chinese)</Citation><ArticleIdList><ArticleId IdType="pubmed">25212011</ArticleId></ArticleIdList></Reference><Reference><Citation>Piralla A., Mariani B., Stronati M., Marone P., Baldanti F. Human enterovirus and parechovirus infections in newborns with sepsis-like illness and neurological disorders. Early Hum. Dev. 2014;90(Suppl. 1):S75&#8211;S77. doi: 10.1016/S0378-3782(14)70023-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0378-3782(14)70023-4</ArticleId><ArticleId IdType="pubmed">24709467</ArticleId></ArticleIdList></Reference><Reference><Citation>Britton P.N., Khandaker G., Booy R., Jones C.A. The causes and consequences of childhood encephalitis in Asia. Infect. Disord. Drug Targets. 2014;14 doi: 10.2174/1871526514666141021113317.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1871526514666141021113317</ArticleId><ArticleId IdType="pubmed">25336078</ArticleId></ArticleIdList></Reference><Reference><Citation>Tung W.H., Hsieh H.L., Lee I.T., Yang C.M. Enterovirus 71 induces integrin &#946;1/EGFR-Rac1-dependent oxidative stress in SK-N-SH cells: Role of HO-1/CO in viral replication. J. Cell Physiol. 2011;226:3316&#8211;3329. doi: 10.1002/jcp.22677.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcp.22677</ArticleId><ArticleId IdType="pubmed">21321939</ArticleId></ArticleIdList></Reference><Reference><Citation>Tung W.H., Hsieh H.L., Lee I.T., Yang C.M. Enterovirus 71 modulates a COX-2/PGE2/cAMP-dependent viral replication in human neuroblastoma cells: Role of the c-Src/EGFR/p42/p44 MAPK/CREB signaling pathway. J. Cell Biochem. 2011;112:559&#8211;570. doi: 10.1002/jcb.22946.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcb.22946</ArticleId><ArticleId IdType="pmc">PMC7166325</ArticleId><ArticleId IdType="pubmed">21268077</ArticleId></ArticleIdList></Reference><Reference><Citation>Tung W.H., Hsieh H.L., Yang C.M. Enterovirus 71 induces COX-2 expression via MAPKs, NF-&#954;B, and AP-1 in SK-N-SH cells: Role of PGE(2) in viral replication. Cell Signal. 2010;22:234&#8211;246. doi: 10.1016/j.cellsig.2009.09.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cellsig.2009.09.018</ArticleId><ArticleId IdType="pubmed">19800403</ArticleId></ArticleIdList></Reference><Reference><Citation>Belsham G.J., Sonenberg N. Picornavirus RNA translation: Roles for cellular proteins. Trends Microbiol. 2000;8:330&#8211;335. doi: 10.1016/S0966-842X(00)01788-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0966-842X(00)01788-1</ArticleId><ArticleId IdType="pubmed">10878768</ArticleId></ArticleIdList></Reference><Reference><Citation>Schneider R.J., Mohr I. Translation initiation and viral tricks. Trends Biochem. Sci. 2003;28:130&#8211;136. doi: 10.1016/S0968-0004(03)00029-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0968-0004(03)00029-X</ArticleId><ArticleId IdType="pubmed">12633992</ArticleId></ArticleIdList></Reference><Reference><Citation>Hemida M.G., Ye X., Zhang H.M., Hanson P.J., Liu Z., McManus B.M., Yang D. MicroRNA-203 enhances coxsackievirus B3 replication through targeting zinc finger protein-148. Cell Mol. Life Sci. CMLS. 2013;70:277&#8211;291. doi: 10.1007/s00018-012-1104-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-012-1104-4</ArticleId><ArticleId IdType="pmc">PMC11113921</ArticleId><ArticleId IdType="pubmed">22842794</ArticleId></ArticleIdList></Reference><Reference><Citation>Abraham T.M., Sarnow P. RNA virus harnesses microRNAs to seize host translation control. Cell Host Microbe. 2011;9:5&#8211;7. doi: 10.1016/j.chom.2011.01.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2011.01.004</ArticleId><ArticleId IdType="pubmed">21238942</ArticleId></ArticleIdList></Reference><Reference><Citation>Orom U.A., Nielsen F.C., Lund A.H. MicroRNA-10a binds the 5&#8242;MUTR of ribosomal protein mRNAs and enhances their translation. Mol. Cell. 2008;30:460&#8211;471. doi: 10.1016/j.molcel.2008.05.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2008.05.001</ArticleId><ArticleId IdType="pubmed">18498749</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts A.P., Lewis A.P., Jopling C.L. miR-122 activates hepatitis C virus translation by a specialized mechanism requiring particular RNA components. Nucleic Acids Res. 2011;39:7716&#8211;7729. doi: 10.1093/nar/gkr426.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkr426</ArticleId><ArticleId IdType="pmc">PMC3177192</ArticleId><ArticleId IdType="pubmed">21653556</ArticleId></ArticleIdList></Reference><Reference><Citation>Li R., Liu L., Mo Z., Wang X., Xia J., Liang Z., Zhang Y., Li Y., Mao Q., Wang J., et al. An inactivated enterovirus 71 vaccine in healthy children. N. Engl. J. Med. 2014;370:829&#8211;837. doi: 10.1056/NEJMoa1303224.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1303224</ArticleId><ArticleId IdType="pubmed">24571755</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu F., Xu W., Xia J., Liang Z., Liu Y., Zhang X., Tan X., Wang L., Mao Q., Wu J., et al. Efficacy, safety, and immunogenicity of an enterovirus 71 vaccine in China. N. Engl. J. Med. 2014;370:818&#8211;828. doi: 10.1056/NEJMoa1304923.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1304923</ArticleId><ArticleId IdType="pubmed">24571754</ArticleId></ArticleIdList></Reference><Reference><Citation>Farooqi A.A., Fayyaz S., Shatynska-Mytsyk I., Javed Z., Jabeen S., Yaylim I., Gasparri M.L., Panici P.B. Is miR-34a a well equipped swordsman to conquer temple of molecular oncology? Chem. Biol. Drug Des. 2015;86 doi: 10.1111/cbdd.12634.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cbdd.12634</ArticleId><ArticleId IdType="pubmed">26259537</ArticleId></ArticleIdList></Reference><Reference><Citation>Janssen H.L., Reesink H.W., Lawitz E.J., Zeuzem S., Rodriguez-Torres M., Patel K., van der Meer A.J., Patick A.K., Chen A., Zhou Y., et al. Treatment of HCV infection by targeting microRNA. N. Engl. J. Med. 2013;368:1685&#8211;1694. doi: 10.1056/NEJMoa1209026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1209026</ArticleId><ArticleId IdType="pubmed">23534542</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>